← Leaderboards
Larry R Jackson
Duke University
$773,569
Attributed
$773,569
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $161.8K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$773,569 · 1
By mechanism
K01$773,569 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Farshid Guilak$32,330,672
- Kenneth G. Manton$25,808,973
- Francis Joseph McClernon$15,864,633
- Kyle D Allen$11,781,402
- Debra Silver$15,197,188
Others in their field
Other Emerging Leaders on “Acceptability And Feasibility”
- Chanza Baytop · Westat, Inc.$271,217,917
- Ana-Maria Vranceanu · Massachusetts General Hospital$15,621,271
- Nathalie Moise · Columbia University Health Sciences$8,346,255
- Ewa Karina Czyz · University Of Michigan At Ann Arbor$6,738,437
- Evan Michael Graboyes · Medical University Of South Carolina$6,374,251
- Soumitri Sil · Emory University$6,121,427
Research focus
Acceptability And FeasibilityCommunicationAnticoagulantsAdherenceArrhythmiaClinical Trials DesignAwardAwarenessAnticoagulationBenefits And RisksBiomedical ResearchBlack PatientAtrial FibrillationAdoptionCardiacCardiologyCardiovascular SystemCareerCare OutcomesCaringCessation Of LifeClinicClinical PracticeCompetence
Grant awards (5)
Shared Decision-Making to Reduce Racial Disparities in Oral Anticoagulation Use in Patients with Non-Valvular Atrial Fibrillation$148,712
K01 · FY2025 · HL · contact PI
Shared Decision-Making to Reduce Racial Disparities in Oral Anticoagulation Use in Patients with Non-Valvular Atrial Fibrillation$150,562
K01 · FY2024 · HL · contact PI
Shared Decision-Making to Reduce Racial Disparities in Oral Anticoagulation Use in Patients with Non-Valvular Atrial Fibrillation$154,358
K01 · FY2023 · HL · contact PI
Shared Decision-Making to Reduce Racial Disparities in Oral Anticoagulation Use in Patients with Non-Valvular Atrial Fibrillation$158,169
K01 · FY2022 · HL · contact PI
Shared Decision-Making to Reduce Racial Disparities in Oral Anticoagulation Use in Patients with Non-Valvular Atrial Fibrillation$161,768
K01 · FY2021 · HL · contact PI